Financhill
Sell
45

NXGL Quote, Financials, Valuation and Earnings

Last price:
$2.54
Seasonality move :
30.26%
Day range:
$2.52 - $2.65
52-week range:
$1.84 - $5.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.96x
P/B ratio:
3.47x
Volume:
17.3K
Avg. volume:
34.5K
1-year change:
17.57%
Market cap:
$20M
Revenue:
$8.7M
EPS (TTM):
-$0.50
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $674K $1.6M $2M $4.1M $8.7M
Revenue Growth (YoY) -6% 130.12% 32.04% 99.66% 112.47%
 
Cost of Revenues $965K $1.5M $1.8M $3.7M $5.9M
Gross Profit -$291K $8K $256K $374K $2.7M
Gross Profit Margin -43.18% 0.52% 12.5% 9.15% 31.63%
 
R&D Expenses -- $31K $367K $103K $78K
Selling, General & Admin $2M $2.4M $2.8M $3.4M $5.9M
Other Inc / (Exp) $6K $258K -$62K $304K $172K
Operating Expenses $2M $2.6M $3.6M $3.9M $6.3M
Operating Income -$2.3M -$2.6M -$3.3M -$3.5M -$3.6M
 
Net Interest Expenses $10K $2M $1.3M $15K $81K
EBT. Incl. Unusual Items -$2.3M -$4.3M -$4.7M -$3.2M -$3.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
 
Minority Interest in Earnings -- -- -- $31K $182K
Net Income to Common Excl Extra Items -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
 
Basic EPS (Cont. Ops) -$1.05 -$1.45 -$0.85 -$0.56 -$0.50
Diluted EPS (Cont. Ops) -$1.05 -$1.45 -$0.85 -$0.56 -$0.50
Weighted Average Basic Share $2.3M $3M $5.6M $5.7M $6.5M
Weighted Average Diluted Share $2.3M $3M $5.6M $5.7M $6.5M
 
EBITDA -$2.2M -$2.2M -$3.1M -$2.7M -$2.9M
EBIT -$2.3M -$2.3M -$3.4M -$3.2M -$3.4M
 
Revenue (Reported) $674K $1.6M $2M $4.1M $8.7M
Operating Income (Reported) -$2.3M -$2.6M -$3.3M -$3.5M -$3.6M
Operating Income (Adjusted) -$2.3M -$2.3M -$3.4M -$3.2M -$3.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $101K $533K $524K $1.1M $3M
Revenue Growth (YoY) -42.61% 427.72% -1.69% 106.49% 181.05%
 
Cost of Revenues $239K $430K $488K $1.2M $2.3M
Gross Profit -$138K $103K $36K -$87K $779K
Gross Profit Margin -136.63% 19.33% 6.87% -8.04% 25.62%
 
R&D Expenses -- $14K $39K $13K --
Selling, General & Admin $525K $844K $702K $975K $1.5M
Other Inc / (Exp) -- $126K $135K $37K $33K
Operating Expenses $538K $990K $817K $1.1M $1.6M
Operating Income -$676K -$887K -$781K -$1.2M -$841K
 
Net Interest Expenses $5K $878K $2K $5K $16K
EBT. Incl. Unusual Items -$681K -$1.6M -$648K -$1.2M -$824K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$681K -$1.6M -$648K -$1.1M -$850K
 
Minority Interest in Earnings -- -- -- $89K -$26K
Net Income to Common Excl Extra Items -$681K -$1.6M -$648K -$1.1M -$850K
 
Basic EPS (Cont. Ops) -$0.12 -$0.29 -$0.11 -$0.20 -$0.11
Diluted EPS (Cont. Ops) -$0.12 -$0.29 -$0.11 -$0.20 -$0.11
Weighted Average Basic Share $5.6M $5.6M $5.6M $5.7M $7.2M
Weighted Average Diluted Share $5.6M $5.6M $5.6M $5.7M $7.2M
 
EBITDA -$676K -$758K -$429K -$845K -$660K
EBIT -$676K -$761K -$646K -$1.2M -$810K
 
Revenue (Reported) $101K $533K $524K $1.1M $3M
Operating Income (Reported) -$676K -$887K -$781K -$1.2M -$841K
Operating Income (Adjusted) -$676K -$761K -$646K -$1.2M -$810K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $674K $1.6M $2M $4.1M $8.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $857K $1.5M $1.8M $3.7M $5.9M
Gross Profit -$183K $8K $263K $375K $2.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $31K $367K $103K $78K
Selling, General & Admin $2.1M $2.4M $2.8M $3.4M $5.9M
Other Inc / (Exp) $15K $258K -$62K $303K $172K
Operating Expenses $2.1M $2.6M $3.6M $3.9M $6.3M
Operating Income -$2.3M -$2.6M -$3.3M -$3.5M -$3.6M
 
Net Interest Expenses $19K $2M $1.3M $15K $80K
EBT. Incl. Unusual Items -$2.3M -$4.3M -$4.7M -$3.2M -$3.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
 
Minority Interest in Earnings -- -- -- $31K $181K
Net Income to Common Excl Extra Items -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
 
Basic EPS (Cont. Ops) -$0.41 -$0.80 -$0.85 -$0.57 -$0.50
Diluted EPS (Cont. Ops) -$0.41 -$0.80 -$0.85 -$0.57 -$0.50
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$2.2M -$2.1M -$3.1M -$2.7M -$2.9M
EBIT -$2.2M -$2.3M -$3.4M -$3.2M -$3.4M
 
Revenue (Reported) $674K $1.6M $2M $4.1M $8.7M
Operating Income (Reported) -$2.3M -$2.6M -$3.3M -$3.5M -$3.6M
Operating Income (Adjusted) -$2.2M -$2.3M -$3.4M -$3.2M -$3.4M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $1.6M $2M $4.1M $8.7M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.5M $1.8M $3.7M $5.9M --
Gross Profit $8K $263K $375K $2.7M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $31K $367K $103K $78K --
Selling, General & Admin $2.4M $2.8M $3.4M $5.9M --
Other Inc / (Exp) $258K -$62K $303K $172K --
Operating Expenses $2.6M $3.6M $3.9M $6.3M --
Operating Income -$2.6M -$3.3M -$3.5M -$3.6M --
 
Net Interest Expenses $2M $1.3M $15K $80K --
EBT. Incl. Unusual Items -$4.3M -$4.7M -$3.2M -$3.5M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$4.3M -$4.7M -$3.2M -$3.3M --
 
Minority Interest in Earnings -- -- $31K $181K --
Net Income to Common Excl Extra Items -$4.3M -$4.7M -$3.2M -$3.3M --
 
Basic EPS (Cont. Ops) -$0.80 -$0.85 -$0.57 -$0.50 --
Diluted EPS (Cont. Ops) -$0.80 -$0.85 -$0.57 -$0.50 --
Weighted Average Basic Share $21.7M $22.3M $22.7M $26M --
Weighted Average Diluted Share $21.7M $22.3M $22.7M $26M --
 
EBITDA -$2.1M -$3.1M -$2.7M -$2.9M --
EBIT -$2.3M -$3.4M -$3.2M -$3.4M --
 
Revenue (Reported) $1.6M $2M $4.1M $8.7M --
Operating Income (Reported) -$2.6M -$3.3M -$3.5M -$3.6M --
Operating Income (Adjusted) -$2.3M -$3.4M -$3.2M -$3.4M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $32K $13.4M $1.1M $2.7M $1.8M
Short Term Investments -- -- $5.5M -- --
Accounts Receivable, Net $73K $209K $222K $633K $933K
Inventory $233K $291K $502K $1.3M $1.8M
Prepaid Expenses -- -- $63K $64K $46K
Other Current Assets $25K $77K $109K $336K $577K
Total Current Assets $363K $13.9M $7.5M $5.1M $5.1M
 
Property Plant And Equipment $1.4M $2.6M $2.5M $3.4M $3.8M
Long-Term Investments -- -- -- -- --
Goodwill $311K $311K $311K $1.1M $1.1M
Other Intangibles $47K $33K $20K $326K $807K
Other Long-Term Assets $178K $63K $63K $95K $95K
Total Assets $2.3M $17M $10.4M $10M $11M
 
Accounts Payable $658K $254K $265K $1.2M $1.3M
Accrued Expenses $43K $54K $56K $61K $242K
Current Portion Of Long-Term Debt $69K $2M $15K $80K $97K
Current Portion Of Capital Lease Obligations $207K $207K $207K $233K $296K
Other Current Liabilities $170K $326K $264K $677K $364K
Total Current Liabilities $1.3M $2.9M $859K $2.5M $2.5M
 
Long-Term Debt $256K $266K $268K $513K $588K
Capital Leases -- -- -- -- --
Total Liabilities $2.2M $4.9M $2.7M $4.8M $4.9M
 
Common Stock $3K $6K $6K $6K $8K
Other Common Equity Adj -- -- -- -- --
Common Equity $71K $12.1M $7.6M $4.7M $5.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $469K $325K
Total Equity $71K $12.1M $7.6M $5.2M $6.1M
 
Total Liabilities and Equity $2.3M $17M $10.4M $10M $11M
Cash and Short Terms $32K $13.4M $6.6M $2.7M $1.8M
Total Debt $472K $2.3M $283K $838K $685K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $32K $13.4M $1.1M $2.7M $1.8M
Short Term Investments -- -- $5.5M -- --
Accounts Receivable, Net $73K $209K $222K $633K $933K
Inventory $233K $291K $502K $1.3M $1.8M
Prepaid Expenses -- -- $63K $64K $46K
Other Current Assets $25K $77K $109K $336K $577K
Total Current Assets $363K $13.9M $7.5M $5.1M $5.1M
 
Property Plant And Equipment $1.4M $2.6M $2.5M $3.4M $3.8M
Long-Term Investments -- -- -- -- --
Goodwill $311K $311K $311K $1.1M $1.1M
Other Intangibles $47K $33K $20K $326K $807K
Other Long-Term Assets $178K $63K $63K $95K $95K
Total Assets $2.3M $17M $10.4M $10M $11M
 
Accounts Payable $658K $254K $265K $1.2M $1.3M
Accrued Expenses $43K $54K $56K $61K $242K
Current Portion Of Long-Term Debt $69K $2M $15K $80K $97K
Current Portion Of Capital Lease Obligations $207K $207K $207K $233K $296K
Other Current Liabilities $170K $326K $264K $677K $364K
Total Current Liabilities $1.3M $2.9M $859K $2.5M $2.5M
 
Long-Term Debt $256K $266K $268K $513K $588K
Capital Leases -- -- -- -- --
Total Liabilities $2.2M $4.9M $2.7M $4.8M $4.9M
 
Common Stock $3K $6K $6K $6K $8K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- $469K $325K
Total Equity $71K $12.1M $7.6M $5.2M $6.1M
 
Total Liabilities and Equity $2.3M $17M $10.4M $10M $11M
Cash and Short Terms $32K $13.4M $6.6M $2.7M $1.8M
Total Debt $472K $2.3M $283K $838K $685K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
Depreciation & Amoritzation $50K $138K $301K $443K $478K
Stock-Based Compensation $232K $285K $298K $217K $367K
Change in Accounts Receivable $29K -$137K -$13K -$411K -$300K
Change in Inventories -$99K -$58K -$211K -$760K -$432K
Cash From Operations -$1.8M -$2.8M -$3M -$3.2M -$3.9M
 
Capital Expenditures $312K $269K $96K $696K $443K
Cash Acquisitions -- -- -- -$547K -$400K
Cash From Investing -$312K -$269K -$5.6M $4.5M -$775K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $514K $3.1M -- $560K $345K
Long-Term Debt Repaid -- -$115K -$3.7M -$181K -$127K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$115K -- -- -$241K
Cash From Financing $1.9M $16.3M -$3.7M $379K $3.7M
 
Beginning Cash (CF) $261K $32K $13.4M $1.1M $2.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$229K $13.3M -$12.2M $1.6M -$893K
Ending Cash (CF) $32K $13.4M $1.1M $2.7M $1.8M
 
Levered Free Cash Flow -$2.1M -$3M -$3.1M -$3.9M -$4.3M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$681K -$1.6M -$648K -$1.1M -$850K
Depreciation & Amoritzation -$20K -$68K $217K $340K $150K
Stock-Based Compensation $45K $56K $67K $97K $96K
Change in Accounts Receivable $45K -$16K $43K $525K -$39K
Change in Inventories -$76K -$30K -$103K -$172K $27K
Cash From Operations -$423K -$1.2M -$649K -$587K -$859K
 
Capital Expenditures $160K -$121K $8K $85K $69K
Cash Acquisitions -- -- -- -$547K -$400K
Cash From Investing -$160K $121K $473K -$273K -$63K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $103K -- -- $471K --
Long-Term Debt Repaid -- -$15K -$150K -$177K -$38K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$114K
Cash From Financing $458K $13.2M -$150K $294K $1.7M
 
Beginning Cash (CF) $157K $1.3M $1.4M $3.3M $1.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$125K $12.1M -$326K -$566K $748K
Ending Cash (CF) $32K $13.4M $1.1M $2.7M $1.8M
 
Levered Free Cash Flow -$583K -$1.1M -$657K -$672K -$928K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$2.3M -$4.3M -$4.7M -$3.2M -$3.3M
Depreciation & Amoritzation $50K $138K $301K $443K $478K
Stock-Based Compensation $232K $285K $298K $217K $367K
Change in Accounts Receivable $29K -$137K -$13K -$411K -$300K
Change in Inventories -$99K -$58K -$211K -$760K -$432K
Cash From Operations -$1.8M -$2.8M -$3M -$3.2M -$3.9M
 
Capital Expenditures $312K $269K $96K $696K $443K
Cash Acquisitions -- -- -- -$547K -$400K
Cash From Investing -$312K -$269K -$5.6M $4.5M -$775K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $514K $3.1M -- -- --
Long-Term Debt Repaid -- -$115K -$3.7M -$181K -$127K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $1.9M $16.3M -$3.7M $379K $3.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$229K $13.3M -$12.2M $1.6M -$893K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$2.1M -$3M -$3.1M -$3.9M -$4.3M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$4.3M -$4.7M -$3.2M -$3.3M --
Depreciation & Amoritzation $138K $301K $443K $478K --
Stock-Based Compensation $285K $298K $217K $367K --
Change in Accounts Receivable -$137K -$13K -$411K -$300K --
Change in Inventories -$58K -$211K -$760K -$432K --
Cash From Operations -$2.8M -$3M -$3.2M -$3.9M --
 
Capital Expenditures $269K $96K $696K $443K --
Cash Acquisitions -- -- -$547K -$400K --
Cash From Investing -$269K -$5.6M $4.5M -$775K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $3.1M -- $560K $345K --
Long-Term Debt Repaid -$115K -$3.7M -$181K -$127K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$115K -- -- -$241K --
Cash From Financing $16.3M -$3.7M $379K $3.7M --
 
Beginning Cash (CF) $2.7M $29.7M $8.8M $7.2M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $13.3M -$12.2M $1.6M -$893K --
Ending Cash (CF) $16.1M $17.5M $10.4M $6.4M --
 
Levered Free Cash Flow -$3M -$3.1M -$3.9M -$4.3M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock